| Marc Stapley | Chief Executive Officer | FY2025 | |
| John Leite | Global Chief Commercial Officer | FY2025 | |
| Rebecca Chambers | Chief Financial Officer | FY2025 | |
| Annie McGuire | General Counsel and Head of Market Access | FY2025 | |
| Phillip Febbo | Chief Scientific Officer and Chief Medical Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.